Mixed Chimerism of Bone Marrow CD34+Sorted Cells after Matched or Haploidentical Allogeneic Stem Cell Transplantation for Myeloid Malignancies Is Predictive of Relapse

被引:0
|
作者
LE Bris, Yannick
Menard, Audrey
Guillaume, Thierry
Peterlin, Pierre
Garnier, Alice
Le Bourgeois, Amandine
Moreau, Philippe
Mohty, Mohamad
Bene, Marie C.
Chevallier, Patrice
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1930
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Impact on outcomes of mixed chimerism of bone marrow CD34+sorted cells after matched or haploidentical allogeneic stem cell transplantation for myeloid malignancies
    Le Bris, Yannick
    Costes, Domitille
    Bourgade, Raphael
    Guillaume, Thierry
    Peterlin, Pierre
    Garnier, Alice
    Le Bourgeois, Amandine
    Chevallier, Patrice
    Bene, Marie C.
    BONE MARROW TRANSPLANTATION, 2022, 57 (09) : 1435 - 1441
  • [2] Impact on outcomes of mixed chimerism of bone marrow CD34+ sorted cells after matched or haploidentical allogeneic stem cell transplantation for myeloid malignancies
    Yannick Le Bris
    Domitille Costes
    Raphaël Bourgade
    Thierry Guillaume
    Pierre Peterlin
    Alice Garnier
    Amandine Le Bourgeois
    Patrice Chevallier
    Marie C. Béné
    Bone Marrow Transplantation, 2022, 57 : 1435 - 1441
  • [3] Mixed myeloid chimerism and relapse of myelofibrosis after allogeneic stem cell transplantation
    Srour, Samer A.
    Olsonr, Amanda
    Ciurear, Stefan O.
    Desair, Parth
    Bashirr, Qaiser
    Orantr, Betu
    Boser, Prithviraj
    Mehtar, Rohtesh
    Patelr, Keyur P.
    Pemmarajur, Naveen
    Daverr, Naval
    Verstovsekr, Srdam
    Champlinr, Richard E.
    Popatr, Uday R.
    HAEMATOLOGICA, 2021, 106 (07) : 1988 - 1990
  • [4] Bone marrow CD34+molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia
    Malagola, Michele
    Polverelli, Nicola
    Beghin, Alessandra
    Bolda, Federica
    Comini, Marta
    Farina, Mirko
    Morello, Enrico
    Radici, Vera
    Accorsi Buttini, Eugenia
    Bernardi, Simona
    Re, Federica
    Leoni, Alessandro
    Bonometti, Davide
    Brugnoni, Duilio
    Lanfranchi, Arnalda
    Russo, Domenico
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [5] CD 34 Cell Dose is Associated with Less Relapse after Matched but Not Haploidentical Stem Cell Transplantation
    Grosso, Dolores
    Alpdogan, Onder
    Carabasi, Matthew
    Filicko-O'Hara, Joanne
    Gaballa, Sameh
    Kasner, Margaret
    Klumpp, Thomas
    Martinez, Ubaldo
    O'Hara, William J.
    Palmisiano, Neil D.
    Porcu, Pierluigi
    Sun, Michael
    Flomenberg, Neal
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S330 - S331
  • [6] Decreasing donor cell chimerism (DCC) in marrow CD34+ cells indicates relapse in acute myeloid leukemia (AML) after allogeneic stem cell transplantation.
    Scheffold, C
    Kroeger, MJ
    Silling, G
    Leo, R
    Zuehlsdorf, M
    Tchinda, J
    Buechner, T
    Berdel, WE
    Kienast, J
    BLOOD, 2001, 98 (11) : 405A - 405A
  • [7] Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation
    Bornhaeuser, Martin
    Elschlaegel, Uta
    Platzbecker, Uwe
    Bug, Gesine
    Lutterbeck, Karin
    Kiehl, Michael G.
    Schetelig, Johannes
    Kiani, Alexander
    Illmer, Thomas
    Schaich, Markus
    Theuser, Catrin
    Mohr, Brigitte
    Brendel, Cornelia
    Fauser, Axel A.
    Klein, Stefan
    Martin, Hans
    Ehninger, Gerhard
    Thiede, Christian
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (11): : 1613 - 1617
  • [8] Myeloid Mixed Chimerism and Relapse in Myelofibrosis after Allogeneic Stem Cell Transplant
    Srour, Samer A.
    Desai, Parth
    Ciurea, Stefan O.
    Bashir, Qaiser
    Oran, Betul
    Olson, Amanda L.
    Ahmed, Sairah
    Bose, Prithviraj
    Mehta, Rohtesh S.
    Pemmaraju, Naveen
    Verstovsek, Srdan
    Champlin, Richard E.
    Popat, Uday
    BLOOD, 2017, 130
  • [9] Peripheral Blood CD34+ Donor Chimerism Is Superior to CD3+ Donor Chimerism for Predicting Relapse Following Allogeneic Stem Cell Transplantation for Myeloid Malignancies
    Das, Tongted
    North, Daniel
    Fleming, Shaun
    Kliman, David
    Spencer, Andrew
    Wei, Andrew H.
    Patil, Sushrut S.
    Widjaja, Jacueline
    O'Brien, Maureen
    Curtis, David J.
    BLOOD, 2020, 136
  • [10] Evaluation of chimerism in bone marrow enriched CD34+cells for monitoring of minimal residual disease after allogeneic stem cell transplantation
    Vasileiou, S.
    Baltadakis, I.
    Garofalaki, M.
    Gonianaki, M.
    Loidoris, A.
    Tziotziou, E.
    Vardaka, M.
    Giatra, C.
    Papageorgiou, M.
    Karatza, M-E.
    Papaioannou, P.
    Gigantes, S.
    Apostolidis, I.
    Karakasis, D.
    Harhalakis, N.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S449 - S450